Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?
BJU International · 2026
DOI: 10.1111/bju.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2026. Verfasst von Yash Khanna und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Prostatectomy, Multiparametric Magnetic Resonance Imaging. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objectives
To analyse the utility of adding multiparametric magnetic resonance imaging (mpMRI) with 68 Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in detection of local recurrence (LR) and distant recurrence (DR) in patients with biochemical recurrence (BCR), by describing detection rates over time since radical prostatectomy (RP), describing detection rates at differing prostate‐specific antigen (PSA) intervals, and identifying clinicopathological factors that predict detection of recurrence on imaging. Patients and Methods Patients with BCR after RP were identified from 2016 to 2020. Kaplan–Meier analysis was performed for LR and DR on mpMRI, 68 Ga‐PSMA PET/CT, and paired/combined scans, and multivariate regression was performed identifying predictors of LR and DR.
Results
A total of 117 patients underwent 150 sets of paired scans for BCR after RP, at PSA thresholds 0.2, 0.5, and 1.0 ng/mL. The 68 Ga‐PSMA PET/CT had higher detection rates of DR at PSA levels of 1.0 ng/mL vs mpMRI (6.1%, 10%, 25% and 36% vs 3%, 6.7%, 6.3%, and 24%, respectively). Meanwhile, mpMRI had higher detection rate of LR than 68 Ga‐PSMA PET/CT (30.3%, 33.3%, 40.6%, and 40% vs 0%, 13.3%, 18.8%, and 32%, respectively). The detection rate for LR was significantly higher on MRI compared to PSMA at PSA levels of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
- Monash Health, Clayton, Victoria, Australia.
- Australian Urology Associates, Malvern, Victoria, Australia.
- Northern Health, Epping, Victoria, Australia.
- Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia.
- Lumus Imaging, Richmond, Victoria, Australia.
ORCID-Profile: Yash Khanna, Vidyasagar Chinni, Weranja K B Ranasinghe
Zitieren
APA
Khanna, Y., Chinni, V., Gnanasambantham, K., Paul, E., O'Sullivan, R., Ballok, Z. E., Ryan, A., Ramdave, S., Sivaratnam, D., Bowden, P., Guerrieri, M., Ranasinghe, W. K. B., & Frydenberg, M. (2026). Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?. BJU International. https://doi.org/10.1111/bju.70115
Vancouver
Khanna Y, Chinni V, Gnanasambantham K, Paul E, O'Sullivan R, Ballok ZE, et al. Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?. BJU International. 2026. doi:10.1111/bju.70115
BibTeX
@article{Khanna2026,
author = {Khanna, Yash and Chinni, Vidyasagar and Gnanasambantham, Kavitha and Paul, Eldho and O'Sullivan, Richard and Ballok, Zita E and Ryan, Andrew and Ramdave, Shakher and Sivaratnam, Dinesh and Bowden, Patrick and Guerrieri, Mario and Ranasinghe, Weranja K B and Frydenberg, Mark},
title = {Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?},
journal = {BJU International},
year = {2026},
doi = {10.1111/bju.70115}
}
EUVIMED